Andrew Elson, MD
Radiation Oncology · Baton Rouge, LANPI 1649596107
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,415 of the $2,324 with a category attached, or 60.9%. Siemens Medical Solutions USA, Inc. accounts for 60.8% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $1,555, more than ten times the $100 reported in 2019.
Across 37 payments — averaging $62.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$1K
- Novocure Inc.$155
- Sumitomo Pharma America, Inc.$136
- Teleflex LLC$99
- Profound Medical Corp.$91
- Boston Scientific$82
- plus $348 from 12 others
What the payments were for
- Travel & lodging$90939%
- Food & beverage$1,41561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 9 | $1,414 |
| Novocure Inc. | 2 | $155 |
| Sumitomo Pharma America, Inc. | 7 | $136 |
| Teleflex LLC | 1 | $99 |
| Profound Medical Corp. | 1 | $91 |
| Boston Scientific | 1 | $82 |
| Daiichi Sankyo Inc. | 3 | $72 |
| Johnson & Johnson | 3 | $64 |
| Novartis | 1 | $34 |
| Adaptive Biotechnologies Corporation | 1 | $25 |
| Bioprotect Medical, Inc. | 1 | $23 |
| Sobi, Inc | 1 | $22 |
| Exelixis Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $20 |
| GE HealthCare | 1 | $19 |
| Progenics Pharmaceuticals, Inc. | 1 | $18 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Incyte Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Varian Ethos Treatment Planning$1,048
- Varian Treatment$197
- TrueBeam$139
- Optune$137
How this compares
$2,324 in reported general payments places this provider in the 80th percentile of 58 radiation oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nystatin | 28 | $555 |
| Lidocaine Hcl ViscousLidocaine Hcl | 17 | $369 |
| Ondansetron Hcl | 18 | $299 |
| Oxycodone Hcl | 16 | $208 |
| Promethazine Hcl | 13 | $188 |
| Tamsulosin Hcl | 37 | $163 |
| Ciprofloxacin Hcl | 29 | $84 |
| Pantoprazole Sodium | 11 | $59 |
| Lorazepam | 18 | $20 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Baton Rouge
- Konstantin KovtunBaton Rouge$3K
- Divyang MehtaBaton Rouge$987
- Maurice KingBaton Rouge$701
- Charles WoodBaton Rouge$448
- Rockne HymelBaton Rouge$347
- Andrew LauveBaton Rouge$305
- Michael DzedaBaton Rouge$153
- Maurice KingBaton Rouge$143
- Jingya WangBaton Rouge$131
- Gregory HenkelmannBaton Rouge$117
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.